Plot No. C40, Road No. 21Y, MIDC, Wagle Industrial Estate, Thane(W)-400604, MH, India
Microbiology Testing FAQs — Methods & Media | HiMedia USA
What is USP <71> Sterility Testing?
USP <71> Sterility Tests is a pharmacopeial test used to determine whether pharmaceutical products, medical devices, biologics, or other articles labeled as sterile are free from viable contaminating microorganisms. It specifies procedures, media requirements, incubation conditions, and acceptance criteria. The test applies to products such as injectable drugs, vaccines, biologics, ophthalmic solutions, parenteral nutrition products, sterile powders, medical implants, and certain other sterile devices. It detects the presence or absence of microbial contamination rather than quantifying the microbial load and is performed using either membrane filtration or direct inoculation methods.
What are the regulatory benefits of using HiVeg media for sterility testing?
HiVeg® media regulatory advantages: (1) Eliminates BSE/TSE documentation requirements for animal products, (2) Simplifies raw material traceability, (3) Meets stricter European regulations on animal-derived materials, (4) Supports Halal/Kosher pharmaceutical certification, (5) Reduces regulatory scrutiny in inspections, (6) Aligns with growing preference for plant-based alternatives globally. Documentation burden is significantly reduced compared to traditional media requiring animal product sourcing verification.
Is HiVeg TSB performance identical to standard TSB for sterility testing?
Yes, Tryptic Soy HiVeg® Broth (MV011) demonstrates equivalent performance to standard TSB in USP <71> testing. Growth promotion validation with ATCC strains (Bacillus subtilis, Candida albicans, Aspergillus brasiliensis) shows comparable or superior recovery. The plant-based peptones provide equivalent nutritional support while eliminating animal-derived materials. Suitable for pharmaceutical GMP applications.
What is the cost comparison between dehydrated and RTU TSB?
500g of MH011 makes ~16.79 liters. At 20mL per tube: yields ~839 tubes. RTU TSB costs approximately 2-3x more per tube but includes labor savings, glassware, sterilization cost, batch consistency , contamination prevention, GMP compliance, and guaranteed performance. Break-even analysis: High-volume facilities (>500 tests/month) see cost savings with dehydrated. Low-medium volume (<200 tests/month) benefit more from RTU. Consider total cost including labor, QC, waste, and risk. In case of RTU, saves quality control testing cost of dehydrated culture media and assures consistent quality
How do I prepare dehydrated Tryptic Soy Broth?
Suspend 29.77 g of MH011 powder in 1000mL purified Water. Mix thoroughly and heat if necessary to dissolve the medium completely. Dispense into tubes or bottles as needed. Sterilize by autoclaving at 121°C (15 psi) for 15 minutes. Final pH should be 7.3±0.2 at 25°C. Prepared medium is clear to slightly opalescent. Store at 15-30°C, Use within shelf life. For sterility testing, prepare in volumes appropriate to sample size.
When is 70mL TSB required vs recommended?
70mL TSB is required when: (1) Sample volume >7mL (to maintain 1:10 ratio), (2) Testing preserved products needing 1:100 dilution, (3) Product validation data shows 20mL insufficient. Recommended when: (1) Testing biological products with low microbial tolerance, (2) Membrane filtration of large volume products, (3) Regulatory guidance suggests larger volumes, (4) Historical contamination issues warrant maximum sensitivity. Consult USP <71> and product-specific monographs.
What is the difference between 20mL and 70mL TSB formats?
LQ009A (70mL) provides larger medium volume for: (1) Membrane filtration sterility testing with multiple filters per container, (2) Testing large volume parenterals or biologics, (3) Pooling multiple sample units, (4) Applications requiring greater dilution of preservatives, (5) Reduced sample-to-medium ratios for enhanced sensitivity. Standard 20mL (LQ009) is sufficient for most injectable testing. Choose 70mL for LVPs, biologics >50mL, or when validations require maximum dilution.
How long does it take to get results from sterility testing with TSB?
USP <71> requires minimum 14 days incubation for both TSB and FTM. However, most contamination is detected within 3-7 days. Daily visual inspection for turbidity, color change, or visible growth. Many labs examine: Days 1-5 daily, Days 6-14 every 2-3 days. Positive results must be confirmed by subculture and identification. Some regulatory agencies accept 7-day incubation for specific validated products, but 14 days is standard. Rapid methods (ATP bioluminescence, PCR) provide faster results but aren't USP <71> compliant.
What is the composition of Tryptic Soy Broth?
TSB contains: Trypticase peptone (17 g/L) - provides amino acids and peptides; Soya peptone (3 g/L) - provides carbohydrates and vitamins; Sodium chloride (5 g/L) - maintains osmotic balance; Dipotassium hydrogen phosphate (2.5 g/L) - buffering; Dextrose (2.5 g/L) - energy source. Final pH 7.3±0.2. This nutrient-rich formulation supports rapid growth of diverse microorganisms. No inhibitory substances, making it suitable for stressed or injured cells.
Can I use TSB for bacterial culture outside of sterility testing?
Yes, TSB is an excellent general-purpose enrichment broth for cultivation of aerobic and facultative anaerobic bacteria. Applications include: (1) Pre-enrichment in food microbiology, (2) Revival of stressed organisms, (3) Biomass production, (4) Antibiotic susceptibility test inoculum preparation, (5) Sub-culturing from agar plates, (6) Blood culture bottle enrichment. Supports growth of fastidious organisms including Streptococcus, Neisseria, Listeria, and Brucella species.
How many TSB tubes are required per sterility test?
Per USP <71>, use at least 2 TSB tubes per sterility test, plus 2 FTM tubes (4 tubes total minimum). For membrane filtration of large volume products: test each filter in separate medium containers. For products in containers >40mL: test contents from each container in separate medium. For validation studies: include positive controls (known viable organisms) and negative controls (uninoculated media). Number of tubes increases with product batch size and regulatory requirements.
What organisms are detected with TSB that might be missed by FTM?
TSB at 20-25°C preferentially recovers: (1) Candida species (common yeast contaminants), (2) Aspergillus species (common mold contaminants), (3) Other filamentous fungi, (4) Psychrophilic bacteria from Water systems, (5) Environmental organisms adapted to room temperature. While FTM can support some fungi, TSB's nutrient-rich formulation and lower incubation temperature maximize fungal recovery. Some fastidious aerobic bacteria also grow better in TSB than FTM.
Why is TSB incubated at 20-25°C instead of 35-37°C?
TSB is incubated at 20-25°C to optimize recovery of fungi (yeasts and molds) and psychrophilic bacteria that may contaminate pharmaceutical products. Many fungal contaminants grow better at room temperature than at body temperature. The lower incubation temperature also reduces metabolic stress on environmental contaminants. This complements FTM incubated at 30-35°C for bacteria. Together, the two temperature ranges ensure detection of the broadest possible range of microbial contaminants.
What is Tryptic Soy Broth RTU used for?
Tryptic Soy Broth (TSB) RTU 20mL is used as the aerobic/fungal medium for USP <71> sterility testing. Incubated at 20-25°C, TSB supports growth of aerobic bacteria, yeasts, and molds. Used in combination with Fluid Thioglycollate Medium (FTM at 30-35°C) to provide comprehensive sterility testing coverage. The 20mL format is standard for most pharmaceutical sterility testing applications and accommodates samples up to 2mL volume per tube.
Why is this product available in 300mL bottles instead of tubes?
The 300mL bottle format allows flexible dispensing volumes for membrane filtration sterility testing. After filtering preserved products through 0.45μm or 0.22μm membranes to remove preservatives, filters are transferred to bottles containing neutralizing FTM. The larger volume ensures adequate medium for submerged incubation of membrane filters. Also used for testing large volume parenterals or multiple units in a single container. More cost-effective than individual tubes for high-volume testing. Other required volumes can be customized
What if lecithin and Tween 80 are not sufficient to neutralize my product?
If standard lecithin/Tween concentrations are insufficient: (1) Increase sample dilution to reduce preservative concentration, (2) Use membrane filtration method and rinse thoroughly to remove preservatives, (3) Add additional specific neutralizers (sodium thiosulfate for halogens, beta-lactamase for antibiotics), (4) Use custom media formulations with higher neutralizer concentrations, (5) Employ alternative methods like direct inoculation. Consult USP <71> Table 1 for additional neutralizing agents. HiMedia can formulate customized media.
Do I need to validate neutralization effectiveness?
Yes, USP <71> Section 4 requires validation that neutralizing agents effectively inactivate preservatives without inhibiting microbial growth. Validation steps: (1) Growth promotion test with <100 CFU of test organisms in presence of product, (2) Comparison with growth in media without product, (3) Recovery ≥70% demonstrates adequate neutralization, (4) Test with all preservative concentrations in your product, (5) Include all required ATCC strains. Document validation in your laboratory protocols.
How do soya lecithin and Tween 80 neutralize preservatives?
Soya lecithin neutralizes quaternary ammonium compounds (QACs) like benzalkonium chloride by binding to their cationic sites, inactivating their antimicrobial activity. Tween 80 (polysorbate 80) is a non-ionic surfactant that neutralizes phenolic compounds and helps disperse lipophilic antimicrobials. Together they provide broad-spectrum neutralization while maintaining FTM's ability to support growth of test organisms. Effectiveness must be validated per USP <71> for each specific product and preservative combination.
Which types of pharmaceutical products require FTM with neutralizing agents?
Products requiring neutralizing FTM include: (1) Multi-dose injectables with preservatives (benzalkonium chloride, phenol, cresol), (2) Ophthalmic solutions with BAK or other preservatives, (3) Nasal sprays and inhalation products, (4) Topical pharmaceuticals with antimicrobial agents, (5) Disinfectants and antiseptics for sterility verification, (6) Any product where standard FTM validation shows preservative interference. USP <71> requires demonstrating preservative neutralization.
What is FTM with Soya Lecithin and Tween 80 used for?
LQ270C3 is 300 ml RTU media, contains Fluid Thioglycollate Medium supplemented with 0.5% soya lecithin and 4% Tween 80 (polysorbate 80). These neutralizing agents inactivate quaternary ammonium compounds (benzalkonium chloride), phenolics, and other antimicrobial preservatives commonly found in pharmaceutical products. Essential for sterility testing of preserved products where standard FTM would give false-positive results due to preservative carryover inhibiting microbial growth.
What documentation does HiMedia provide for HiVeg media® validation?
HiMedia provides: (1) Certificate of Analysis (COA) for each lot with QC test results, (2) Technical Data Sheet with formulation and specifications, (3) Growth promotion data with ATCC reference strains, (4) Manufacturing process documentation, (5) ISO 13485 certification, (6) Plant-based peptone source documentation, (7) Comparative performance studies vs traditional media, (8) Regulatory compliance letters. Custom validation support available for pharmaceutical applications.
Which countries or industries prefer HiVeg media?
HiVeg media are particularly popular in: (1) India and Asian markets with cultural preferences for plant-based products, (2) European pharmaceutical manufacturers complying with strict BSE/TSE regulations, (3) Halal and Kosher certified pharmaceutical facilities, (4) Companies with animal-free policies, (5) Manufacturers of vegan/vegetarian therapeutic products, (6) Facilities seeking to eliminate animal product traceability requirements. Growing adoption in US GMP facilities seeking reproducibility improvements.
Do I need to revalidate my sterility testing method when switching to HiVeg® media?
Yes, any media change requires revalidation per USP <71> Section 4.2. Perform: (1) Growth promotion testing with all required ATCC strains, (2) Sterility testing of media lots, (3) Method suitability testing with your specific products, (4) Side-by-side comparison with current media (recommended). While HiVeg® performance is equivalent, regulatory compliance requires validation for your specific application. HiMedia provides validation support documentation and Certificates of Analysis to assist.
Is HiVeg® FTM performance equivalent to standard FTM?
Yes, HiVeg® FTM is performance-validated to meet the same USP <71> specifications as standard FTM. Growth promotion tests with ATCC reference strains (Clostridium sporogenes, Bacteroides vulgatus, Bacteroides fragilis, Pseudomonas aeruginosa, Staphylococcus aureus, Bacillus subtilis, Candida albicans) demonstrate equivalent or superior growth. pH, appearance, and sterility specifications are identical. Many pharmaceutical QC labs have successfully validated HiVeg as a direct replacement for traditional FTM.
What are the advantages of HiVeg® media over traditional animal-based media?
HiVeg® media advantages: (1) No BSE/TSE risk from animal-derived ingredients, (2) Reduced batch-to-batch variability from plant sources, (3) Consistent nutritional composition, (4) Suitable for vegan/vegetarian animal free product manufacturing, (5) Improved regulatory compliance in markets restricting animal products, (6) Better lot-to-lot reproducibility. Performance matches or exceeds traditional formulations in supporting microbial growth for all USP <71> test organisms.
What is HiVeg Fluid Thioglycollate Medium?
MV009 Fluid Thioglycollate HiVeg® Medium is an animal-free formulation using plant-based peptones instead of traditional casein and meat peptones. It maintains identical performance to standard FTM for USP <71> sterility testing while eliminating BSE/TSE risk. HiVeg® media offer consistent batch-to-batch performance, reduced variability, and support for vegan-friendly pharmaceutical manufacturing. Meets all USP, EP, and JP specifications.
Which Media Types are Required for USP <71> Compliance?
USP <71> compliance typically requires the use of two complementary sterility testing media: Fluid Thioglycollate Medium (FTM) and Soybean-Casein Digest Medium (SCDM), also known as Tryptic Soy Broth (TSB). Together, these sterility testing media provide broad microbial recovery capability and support the detection of aerobic, anaerobic, facultative, and fungal contaminants that may be present in pharmaceutical products.
How Do You Validate Sterility Testing Media?
Qualify each media batch before use by assessing its physical appearance, pH, sterility, container integrity, and storage conditions. The specified pH is 7.1 ± 0.2 for FTM and 7.3 ± 0.2 for SCDM. Perform Growth Promotion Testing (GPT) with a low inoculum of 10–100 CFU using appropriate pharmacopeial reference strains, such as Clostridium sporogenes, Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus spizizenii (Bacillus subtilis), Candida albicans, and Aspergillus brasiliensis (Aspergillus niger). Finally, perform method suitability testing to confirm that the product does not inhibit microbial recovery.
What are Common USP <71> Compliance Challenges?
Common USP <71> compliance challenges include false-positive or false-negative results, environmental contamination, inadequate media performance, Growth Promotion Testing (GPT) failures, and method suitability issues. Improper media preparation, storage, or incubation conditions, along with poor aseptic practices and equipment control, can affect microbial recovery. Documentation deficiencies may also create compliance concerns. Effective contamination control, validated procedures, trained personnel, quality checks, and complete documentation help minimize these risks and support reliable sterility testing.
When Should You Perform Sterility Testing?
Sterility testing is performed when required by regulatory guidelines, product specifications, manufacturing processes, or quality systems to confirm that a product is free from viable microorganisms. USP <71> has been harmonized with corresponding texts of the European Pharmacopoeia and/or Japanese Pharmacopoeia, with sterility assurance primarily supported by validation of the sterilization process or aseptic processing procedures. Sterility testing may be required for batch release, process validation, stability studies, and investigations of suspected contamination. It provides evidence that products intended to be sterile meet defined quality, safety, and sterility requirements before use or release.
Showing 30 FAQs